Literature DB >> 9797022

Aromatase expression in the human breast.

A Brodie1, B Long, Q Lu.   

Abstract

The plasma levels of free estradiol are very low in postmenopausal women. However, concentrations of estrogens within breast tissue have been reported to be higher than in plasma and similar to plasma concentrations in premenopausal women. One mechanism by which this may occur is for breast cells to synthesize estrogens themselves and produce high concentrations locally. Thus, tumor aromatase may be a significant source of estrogen which stimulates tumor growth. To address the question of the importance of this pathway, we have investigated the expression of aromatase within the normal breast and breast cancers. Because conventional biochemical assays for measuring aromatase activity require relatively large amounts of tissue, we developed an immunocytochemical method using a monoclonal antibody to determine the expression of aromatase. The method can be applied to sections of tumors embedded in paraffin blocks as routinely prepared for pathology. Since we have previously shown that mRNA for aromatase (P450 arom) and the protein are expressed in the same cells of the human placenta, we used in situ hybridization of sequence specific probes to P450 arom mRNA in breast tissue as one method to verify the specificity of the immunocytochemical detection of the enzyme. Both immunocytochemistry and in situ hybridization identified aromatase enzyme and mRNA expression in the epithelial cells of the terminal ductal lobula units (TDLU) and surrounding stromal cells of the normal human breast, and in the tumor epithelial cells and stromal cells of breast cancers. In addition, evidence for the functional significance of tumor aromatase was indicated by a correlation between aromatase activity and expression of proliferating cell nuclear antigen (PCNA) in the tumor, and by increased thymidine incorporation into DNA in response to testosterone in tumors in histoculture which had high aromatase activity but not in those with low activity. The findings suggests that estrogen produced locally is important in enhancing proliferation of the tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797022     DOI: 10.1023/a:1006029612990

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

Review 2.  The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.

Authors:  Aruna V Krishnan; Srilatha Swami; David Feldman
Journal:  Steroids       Date:  2012-07-16       Impact factor: 2.668

Review 3.  Aromatase inhibitors and inactivators for breast cancer therapy.

Authors:  Per E Lønning
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  The transdermal patches for site-specific delivery of letrozole: a new option for breast cancer therapy.

Authors:  Li Li; Xinlan Xu; Liang Fang; Yu Liu; Yinghua Sun; Mangli Wang; Nanxi Zhao; Zhonggui He
Journal:  AAPS PharmSciTech       Date:  2010-06-26       Impact factor: 3.246

5.  Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer.

Authors:  Masashi Demura; Yoshiki Demura; Shingo Ameshima; Takeshi Ishizaki; Masato Sasaki; Isamu Miyamori; Masakazu Yamagishi; Yoshiyu Takeda; Serdar E Bulun
Journal:  Lung Cancer       Date:  2011-02-12       Impact factor: 5.705

6.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

7.  Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

Authors:  Aruna V Krishnan; Srilatha Swami; Lihong Peng; Jining Wang; Jacqueline Moreno; David Feldman
Journal:  Endocrinology       Date:  2009-11-11       Impact factor: 4.736

8.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 9.  Nuclear receptors as modulators of the tumor microenvironment.

Authors:  Mara H Sherman; Michael Downes; Ronald M Evans
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

Review 10.  Endocrine Therapy in Early Breast Cancer.

Authors:  Katja Krauss; Elmar Stickeler
Journal:  Breast Care (Basel)       Date:  2020-07-21       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.